Thyroid Biology and Disease

MTP03 - Recent Advances in the Management of Anaplastic Thyroid Cancer

Saturday, June 13, 2026

9:45 AM - 10:25 AM CT

Location: Room W375C

Meet the Professor Speaker(s)

Maria E. Cabanillas, MD

Professor
The University of Texas MD Anderson Cancer Center
Houston, TX, United States

Disclosure(s):

Maria E. Cabanillas, MD: Bayer Inc.: Consultant (); EISAI: Research funding (); Exelixis: Consultant (), Research funding (); Genentech: Research funding (); Lilly: Consultant (); Merck: Research funding (); Novartis: Consultant ()

Learning Objectives:

Describe the necessary baseline testing to determine the best treatment of anaplastic thyroid cancer (ATC).
Describe the optimal management of BRAF V600E-variant ATC.
Describe the current management of non–BRAF V600E-variant ATC.